Westfield Capital Management CO LP Novo Cure LTD Transaction History

Westfield Capital Management CO LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 13, 2019	SELL	$42.22 - $63.23 $12.9 Million - $19.3 Million	-305,185 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$31.96 - $56.12 $12.2 Million - $21.4 Million	-380,705 Reduced 55.51%	305,185 $14.7 Million
Q4 2018 Feb 08, 2019	BUY	$28.72 - $52.63 $13.8 Million - $25.3 Million	480,085 Added 233.27%	685,890 $23 Million
Q3 2018 Nov 14, 2018	SELL	$32.0 - $52.4 $9.72 Million - $15.9 Million	-303,805 Reduced 59.62%	205,805 $10.8 Million
Q2 2018 Aug 13, 2018	BUY	$19.85 - $32.0 $1.06 Million - $1.71 Million	53,575 Added 11.75%	509,610 $16 Million
Q1 2018 May 14, 2018	SELL	$19.3 - $23.65 $1.06 Million - $1.3 Million	-54,765 Reduced 10.72%	456,035 $9.94 Million
Q4 2017 Feb 13, 2018	BUY	$16.3 - $21.9 $8.33 Million - $11.2 Million	510,800	510,800 $10.3 Million

263

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $3.23B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Westfield Capital Management CO LP, based on Form 13F filings with the SEC.

Stay updated on Westfield Capital Management CO LP with notifications on news.